NOVEL ASSOCIATION BETWEEN 4-{3-[CIS-HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)-YL]PROPOXY}BENZAMIDE AND AN NMDA RECEPTOR ANTAGONIST AND THE PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN SAID ASSOCIATION
An association between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}benzamide of formula (I), or one of the addition salts thereof with a pharmaceutically acceptable acid or base and an NMDA glutamate receptor antagonist. Drugs.Association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}benzamide de formule (I), ou un de ses sels d'addition à un acide ou à une base pharmaceutiquement acceptable et un antagoniste des récepteurs glutamatergiques NMD A. Médicaments.